Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Israel will be hit by 2,000 Missiles a Day

Lebanon, OC Home Front Command Maj.-Gen. Uri Gordin warned…
Read more

Contactless Visa SBI Credit Card

Contactless payment is becoming more and more prevalent especially…
Read more

Brexit Wars Recommence

The Brexit Wars continue as the European Union launches legal…
Read more